(Q36793085)

16 August 2017

title

Evidence-based guidelines for following stage 1 seminoma (English)

1 reference

16 August 2017

Jarad M Martin

1

1 reference

16 August 2017

Tony Panzarella

2

1 reference

16 August 2017

Daniel R Zwahlen

3

1 reference

16 August 2017

Peter Chung

4

1 reference

16 August 2017

Padraig Warde

5

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

16 August 2017

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

16 August 2017

volume

109

1 reference

16 August 2017

issue

11

1 reference

16 August 2017

page(s)

2248-2256

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

Surveillance following orchidectomy for stage I testicular seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

Low-dose computed tomography surveillance of patients with testicular tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

The role of CT scanning in the surveillance of testicular tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

Trends in the incidence of testicular germ cell tumors in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Robust Locally Weighted Regression and Smoothing Scatterplots

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Surveillance in stage I testicular cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Surveillance following orchidectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Testicular Seminoma in Denmark 1976–1980 Results of Treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Late recurrences of germ cell malignancies: a population-based experience over three decades

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

One-dose carboplatin in seminoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Short course para-aortic radiation for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Imaging of testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Hidden by HIPAA: the costs of cure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22674

7 January 2021

Identifiers

DOI

10.1002/CNCR.22674

1 reference

16 August 2017

1 reference